Re: QBI COVID-19 research results
|
|
Resverlogix Corp.
|
May 01, 2020 06:21AM
|
Re: Q4 2019 Events
|
3
|
Resverlogix Corp.
|
Oct 01, 2019 05:52PM
|
Re: Q1- March 31, 2022 on SEDAR
|
6
|
Resverlogix Corp.
|
May 17, 2022 09:38AM
|
Re: Q1- March 31, 2022 on SEDAR
|
5
|
Resverlogix Corp.
|
May 17, 2022 12:53PM
|
Re: Q1- March 31, 2022 on SEDAR
|
2
|
Resverlogix Corp.
|
May 17, 2022 01:12PM
|
Re: Q1- March 31, 2022 on SEDAR
|
1
|
Resverlogix Corp.
|
May 21, 2022 06:55AM
|
Re: Q1- March 31, 2022 on SEDAR
|
5
|
Resverlogix Corp.
|
May 14, 2022 02:54PM
|
Re: Q1- March 31, 2022 on SEDAR
|
3
|
Resverlogix Corp.
|
May 14, 2022 06:13PM
|
Re: Q1- March 31, 2022 on SEDAR
|
6
|
Resverlogix Corp.
|
May 22, 2022 07:43AM
|
Re: Q1- March 31, 2022 on SEDAR
|
7
|
Resverlogix Corp.
|
May 22, 2022 03:02PM
|
Re: Q1- March 31, 2022 on SEDAR
|
3
|
Resverlogix Corp.
|
May 16, 2022 06:46AM
|
Re: Q1- March 31, 2022 on SEDAR
|
4
|
Resverlogix Corp.
|
May 16, 2022 10:10AM
|
Re: Q1- March 31, 2022 on SEDAR
|
4
|
Resverlogix Corp.
|
May 16, 2022 10:33AM
|
Re: Q1- March 31, 2022 on SEDAR
|
1
|
Resverlogix Corp.
|
May 16, 2022 12:51PM
|
Re: Providence Therapeutics
|
|
Resverlogix Corp.
|
Sep 14, 2021 04:04PM
|
Re: Prothena is our ticket now or never
|
1
|
BIOASIS TECHNOLOGIES INC
|
Aug 09, 2021 10:43AM
|
Re: Prospects for resverlogix
|
5
|
Resverlogix Corp.
|
Jul 15, 2020 11:54AM
|
Re: Promissory Notes
|
|
Zenith Epigenetics
|
Apr 11, 2023 11:08AM
|
Re: Promissory Note
|
3
|
Zenith Epigenetics
|
Mar 10, 2021 07:12AM
|
Re: Prof Kausik Ray's latest latest tweet
|
|
Resverlogix Corp.
|
Nov 16, 2019 09:16AM
|